Culture Biosciences’ new cutting-edge Stratyx 250 Bioreactor technology is designed to transform your workflows, delivering real-time data and insights to accelerate decision-making. With enhanced scalability, and seamless integration, it streamlines operations, boosts productivity, and reduces costs. Whether you’re scaling experiments or optimizing processes, our hardware empowers you to achieve faster, more efficient results while driving significant cost savings.
Reduce Costs & Boost Productivity:
The Stratyx 250 enhances productivity with real-time data and actionable insights, achieving a 35% increase in experiment throughput. Drive down operational costs while maintaining consistent, scalable performance across experiments.
The Stratyx 250 features modular bays that allow flexible configurations, adapting to your lab’s space and throughput requirements. This modular setup provides seamless mobility, and economical use of lab space, and hastened scalability, which offers a true advantage for companies investing in modular bioreactor platforms.
Designed with the user in mind, Stratyx 250 simplifies complex workflows with:
The Stratyx 250 makes sure you have a unified, efficient user experience across every aspect of your bioprocess development. With our innovative bioreactor technology, we deliver a future-ready solution.
Culture’s new Stratyx 250 hardware combines cutting-edge bioreactor technology with end-to-end operational support to help you speed up your experiments to achieve development success, faster.
With a team that has deep experience in bioprocessing and the latest software technologies, Culture has a proven track record of helping process developers optimize their experiments.
Sign up for regular updates, including new blog posts and announcements.
